Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
startups
3
×
clinical trials
deals
investing
new york blog main
new york top stories
allosteric
antisense oligonucleotide
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
brace pharma
cleva pharma
columbia university
dacogen
david goldstein
decitabine
depression
dna
drug discovery
dupilumab
epi4k
epigenetics
epilepsy
epizyme
essential tremor
farydak
What
medicines
3
×
new
3
×
aims
drugs
research
therapeutics
address
adds
ago
allosteric
approach
backed
based
biotech
called
cause
ceo
clinic
debuts
developing
disease
elusive
epigenetic
epigenetics
epilepsy
field
flagship’s
genes
genetic
hotspot
links
marcio
molecules
morning
mutations
neuro
omega
path
potential
praxis
Language
unset
Current search:
new
×
startups
×
boston
×
" boston blog main "
×
medicines
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further